Pulsed field ablation in atrial fibrillation ablation: where are we and where are we going?

Pulsed field ablation (PFA) offers a novel approach to treating atrial fibrillation, demonstrating promising efficacy and safety. Unlike traditional thermal ablation techniques like radiofrequency or cryoablation, PFA uses non-thermal irreversible electroporation to selectively target myocardial tissue, minimizing damage to surrounding structures such as the oesophagus, phrenic nerve, and coronary arteries. Initial studies indicate that PFA is effective in achieving durable pulmonary vein isolation and posterior wall isolation, with a low incidence of serious complications. However, more long-term clinical data are needed to further confirm its efficacy.

Authors

Institutions

Publication Details

Journal
European Heart Journal Supplements
Published
2025-02-01
DOI
https://doi.org/10.1093/eurheartjsupp/suae103
Citations
3
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
4.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulsed field ablation in atrial fibrillation ablation: where are we and where are we going?

Claudio Tondo, Marco Schiavone
3 citations
European Heart Journal Supplements
Atrial Fibrillation Management and Outcomes
4.16
article

Pulsed field ablation in atrial fibrillation ablation: where are we and where are we going?

Claudio Tondo, Marco Schiavone
article en
3 citations

Abstract

Pulsed field ablation (PFA) offers a novel approach to treating atrial fibrillation, demonstrating promising efficacy and safety. Unlike traditional thermal ablation techniques like radiofrequency or cryoablation, PFA uses non-thermal irreversible electroporation to selectively target myocardial tissue, minimizing damage to surrounding structures such as the oesophagus, phrenic nerve, and coronary arteries. Initial studies indicate that PFA is effective in achieving durable pulmonary vein isolation and posterior wall isolation, with a low incidence of serious complications. However, more long-term clinical data are needed to further confirm its efficacy.

European Heart Journal SupplementsVol. 27(Supplement_1)
University of Rome Tor Vergata (IT), University of Milan (IT), Centro Cardiologico Monzino (IT)
Openalex Percentile: Top 7%
Atrial Fibrillation Management and Outcomes
4.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.